- Home
- MMSI
as 04-18-2025 1:39pm EST
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Upcoming Earnings Alert:
Get ready for potential market movements as Merit Medical Systems Inc. MMSI prepares to release earnings report on 24 Apr 2025.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | SOUTH JORDAN |
| Market Cap: | 5.5B | IPO Year: | 1990 |
| Target Price: | $114.33 | AVG Volume (30 days): | 850.7K |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.03 | EPS Growth: | 25.31 |
| 52 Week Low/High: | $70.70 - $111.45 | Next Earning Date: | 04-24-2025 |
| Revenue: | $1,356,514,000 | Revenue Growth: | 7.88% |
| Revenue Growth (this year): | 11.31% | Revenue Growth (next year): | 6.09% |
Stock Insider Trading Activity of Merit Medical Systems Inc. (MMSI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Peterson Neil | MMSI | CHIEF OPERATING OFFICER | Apr 1 '25 | Sell | $104.53 | 5,000 | $522,650.00 | 28,369 | |
| Parra Raul Jr. | MMSI | CFO AND TREASURER | Mar 5 '25 | Sell | $103.58 | 5,361 | $555,292.38 | 24,201 | |
| LAMPROPOULOS FRED P | MMSI | President and CEO | Mar 5 '25 | Sell | $103.90 | 31,320 | $3,252,846.00 | 1,106,028 | |
| Lloyd Brian G. | MMSI | CHIEF LEGAL OFFICER, SECRETARY | Mar 4 '25 | Sell | $102.90 | 30,000 | $3,087,000.00 | 38,945 | |
| Peterson Neil | MMSI | CHIEF OPERATING OFFICER | Mar 3 '25 | Sell | $105.00 | 5,000 | $525,000.00 | 28,369 | |
| Evans Stephen C. | MMSI | Director | Mar 3 '25 | Sell | $105.31 | 5,000 | $526,550.00 | 4,657 | |
| Lloyd Brian G. | MMSI | CHIEF LEGAL OFFICER, SECRETARY | Feb 27 '25 | Sell | $99.50 | 25,000 | $2,487,500.00 | 38,945 | |
| Voigt Michel James | MMSI | CHIEF HUMAN RESOURCES OFFICER | Feb 27 '25 | Sell | $99.68 | 13,809 | $1,376,481.12 | 22,399 | |
| Parra Raul Jr. | MMSI | CFO AND TREASURER | Feb 27 '25 | Sell | $98.81 | 12,451 | $1,230,283.31 | 24,201 |
Latest Merit Medical Systems Inc. News
MMSI Breaking Stock News: Dive into MMSI Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
StockStory
2 days ago
Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)
Argus Research
3 days ago
MMSI: Raising target price to $97.00
Zacks
4 days ago
Merit Medical Stock Slips Despite the Launch of New Ventrax System
Zacks
5 days ago
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Zacks
9 days ago
Merit Medical (MMSI) Surges 8.3%: Is This an Indication of Further Gains?
GlobeNewswire
10 days ago
Merit Medical Launches the Ventrax™ Delivery System
Argus Research
10 days ago
MMSI: Lowering target price to $93.00
Compare MMSI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MMSI Merit Medical Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.